Awarded the Nobel Prize in 1975 for research in virology, Baltimore has profoundly influenced national science policy on such issues as recombinant DNA research and the AIDS epidemic.ĭr Baltimore graduated from Swarthmore College with a degree in chemistry. He is an honorary professor at University College, London and at King’s College, London, and a Special Visiting Professor at the University of Hong Kong.ĭavid Baltimore is President Emeritus and Judge Shirley Hufstedler Professor of Biology at Caltech. He was awarded a CBE in the 2018 New Year’s Honours List. He has received the Louis Jeantet Prize for Medicine (1995), the Amory Prize (1996), the Feldberg Foundation Prize (2008), the Waddington Medal of the British Society for Developmental Biology (2010), the ISSCR Public Service Award (2021), and the Genetics Society Medal (2022). He was elected a member of EMBO (1993), a Fellow of the Academy of Medical Sciences (1999), the Royal Society (2001), the Royal Society of Biology (2011), and the American Association for the Advancement of Science (AAAS) (2018). He chairs the Royal Society’s Genetic Technologies Programme and has been involved in the human genome editing Summit meetings since their inception. He is also very active in both public engagement and policy work, notably around stem cells, genetics, human embryo and animal research, and in ways science is regulated and disseminated. Major themes of his current work include sex determination, development of the nervous system and pituitary, and the biology of stem cells within these systems. He has had long-standing interests in the biology of stem cells, in how genes work in the context of embryo development, and how decisions of cell fate are made. In 1990, his lab discovered Sry, the Y-linked sex determining gene and the first members of the Sox gene family. The NIMR was incorporated into the Francis Crick Institute in April 2015. In 1988 he moved to the MRC National Institute for Medical Research, becoming Head of the Division of Stem Cell Biology and Developmental Genetics in 1993. After an EMBO fellowship in Paris he established his independent laboratory in 1982 at the MRC Mammalian Development Unit, UCL, directed by Anne McLaren. Robin Lovell-Badge obtained his PhD at University College London in 1978 and was a postdoc in Cambridge, both with Martin Evans. Recordings of all the presentations are available to watch. In preparation for the Summit, a three-part series of online events was held in 2022 'Looking Ahead to the Third Human Genome Editing Summit', which focused on scientific developments, equity and access, and governance of human genome editing. Findings from the report were presented by Piers Millett on Wednesday 8 March at the Summit.Ī recorded presentation on 'CRISPR and Human Genome Editing: Progress & Opportunities' by Jennifer Doudna, Li Ka Shing Chancellor's Chair Professor in the Department of Chemistry and the Department of Molecular and Cell Biology, University of California, Berkeley, USA, is available to watch.Ī handout for the agenda session on the morning of Wednesday 8 March 'Civil Society and Human Genome Editing: roles and challenges in public engagement' is available to download. The report of a research project aiming to survey, document, catalogue and analyse empirical information regarding regulatory capacity and governance approaches for somatic genome editing research interventions in different countries, which was commissioned ahead of the Summit, is available to download. The Summit booklet, which includes the agenda, is available to download. Read the closing statement from the Summit's Organising Committee. Watch all three days of the Third International Summit on Human Genome Editing. The Summit’s Organising Committee, chaired by Professor Robin Lovell-Badge FMedSci FRS, released a statement based on the Summit discussions. The three-day Summit was organised by the Royal Society, the UK Academy of Medical Sciences, the US National Academies of Sciences and Medicine and The World Academy of Sciences. Major themes for discussion included developments in clinical trials and genome editing tools such as CRISPR/Cas9, as well as social, ethical and accessibility considerations these scientific developments entail. The Third International Summit on Human Genome Editing took place on 6-8 March 2023 at the Francis Crick Institute, London UK.īuilding on previous events held in Washington, DC ( 2015) and Hong Kong ( 2018), the London meeting continued the global dialogue on somatic and germline human genome editing.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |